BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27402085)

  • 1. Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.
    Giamarellos-Bourboulis EJ; Pyleris E; Barbatzas C; Pistiki A; Pimentel M
    BMC Gastroenterol; 2016 Jul; 16(1):67. PubMed ID: 27402085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.
    Pyleris E; Giamarellos-Bourboulis EJ; Tzivras D; Koussoulas V; Barbatzas C; Pimentel M
    Dig Dis Sci; 2012 May; 57(5):1321-9. PubMed ID: 22262197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?
    Spiegel BM; Chey WD; Chang L
    Am J Gastroenterol; 2008 Dec; 103(12):2972-6. PubMed ID: 19086951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
    Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Bilirubin Is Associated with Small Intestinal Bacterial Overgrowth in Diarrhea Predominant Irritable Bowel Syndrome.
    Kim SY; Seo YS; Lee ES; Kim KN
    Ann Clin Lab Sci; 2019 May; 49(3):344-352. PubMed ID: 31308034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.
    Schmulson MJ; Frati-Munari AC
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):44-51. PubMed ID: 29678362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC; Shukla R; Ghoshal U
    Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Zhuang X; Tian Z; Luo M; Xiong L
    BMC Gastroenterol; 2020 Jun; 20(1):187. PubMed ID: 32532214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
    Reddymasu SC; Sostarich S; McCallum RW
    BMC Gastroenterol; 2010 Feb; 10():23. PubMed ID: 20175924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Small Intestinal Bacterial Overgrowth among Functional Dyspepsia Patients.
    Tziatzios G; Gkolfakis P; Papanikolaou IS; Mathur R; Pimentel M; Damoraki G; Giamarellos-Bourboulis EJ; Dimitriadis G; Triantafyllou K
    Dig Dis; 2021; 39(4):382-390. PubMed ID: 33011725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    Su T; Lai S; Lee A; He X; Chen S
    J Gastroenterol; 2018 Jan; 53(1):27-36. PubMed ID: 28770351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A; Talley NJ; Jones M; Kendall BJ; Koloski N; Walker MM; Morrison M; Holtmann GJ
    Am J Gastroenterol; 2020 Feb; 115(2):190-201. PubMed ID: 31913194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Thyroxine Improves Outcomes in Hypothyroid Patients With Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome.
    Henderson BB; Smith SP; Mengelkamp ME; Rhymer EK; Gray KN; Jackson AG; Henry SF; Chuang S; Stavrakas EH; Blair OM; Heaps M
    Endocr Pract; 2024 Jun; 30(6):505-512. PubMed ID: 38490469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
    Aziz I; Törnblom H; Simrén M
    Curr Opin Gastroenterol; 2017 May; 33(3):196-202. PubMed ID: 28257307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.